RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
RT @BJGPjournal: GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity https://t.co/iYNaiLOAQ9 https://t.…
GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice https://t.co/8DcxUKefMG
RT @BJGPjournal: GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity https://t.co/iYNaiLOAQ9 https://t.…
RT @BJGPjournal: GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity https://t.co/iYNaiLOAQ9
GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity https://t.co/iYNaiLOAQ9
GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice https://t.co/8DcxUKefMG
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @jenniaburt: Loved working on this with a great bunch of colleagues @K_Kuberska @RichardJMcManus @jamessheppard48 @prof_mant amongst oth…
RT @BJGPjournal: GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives…
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @yasukif: Mindlinesに関するリサーチが久しぶりにでましたね。日本の家庭医にとっても大きなテーマだと思っています👉 GPs’ mindlines on deprescribing antihypertensives in older patients wi…
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @K_Kuberska: We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns…
RT @BJGPjournal: GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives…
RT @BJGPjournal: GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives…
RT @BJGPjournal: GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives…
RT @jenniaburt: Loved working on this with a great bunch of colleagues @K_Kuberska @RichardJMcManus @jamessheppard48 @prof_mant amongst oth…
RT @BJGPjournal: GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives…
We argue that in the absence of a clear evidence base on when & how to attempt medication reduction in response to concerns about #polypharmacy, GPs develop #mindlines over time through practice-based experience. #deprescribing #hypetension #GeneralPr
RT @BJGPjournal: GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives…
GPs develop ‘mindlines’ through practice-based experience – tacit approaches critical for deprescribing antihypertensives in older patients with multimorbidity Read the research: https://t.co/iYNaiLOAQ9 @jenniaburt @K_Kuberska @PCU_Cambridge https://t.co/
RT @JHGeriatrics: FYI .@DeprescribeUS & Congrats to .@K_Kuberska #Deprescribing #OlderAdults #MultiMorbidity https://t.co/gfkgfpX2If
RT @JHGeriatrics: FYI .@DeprescribeUS & Congrats to .@K_Kuberska #Deprescribing #OlderAdults #MultiMorbidity https://t.co/gfkgfpX2If
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @Deprescribing: Check this out @wadddee @CarinaLundby @cheryl_sadowski https://t.co/x4DbpAJXiO
RT @Deprescribing: Check this out @wadddee @CarinaLundby @cheryl_sadowski https://t.co/x4DbpAJXiO
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
Check this out @wadddee @CarinaLundby @cheryl_sadowski
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
FYI .@DeprescribeUS & Congrats to .@K_Kuberska #Deprescribing #OlderAdults #MultiMorbidity
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
RT @K_Kuberska: Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity:…
Our paper is finally out! 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice" https://t.co/ODMNqDmZdZ #polypharmacy 💊💊💊💊 #Hypertension https://t.co/DDyuZPoE2P
減薬に対する明確な指針がない状況では,GPは転倒や薬物有害事象などのきっかけなど実践的な経験を通じて時間を掛けてマインドライン(複数の情報源から時間をかけて作成された暗黙の内在化されたガイドライン)を構築する. https://t.co/lrjGCIpXF3
RT @RichardJMcManus: Includes nice paper led by @jenniaburt on how GPs think about deprescribing antihypertensives https://t.co/m65zII7gFe
RT @RichardJMcManus: Includes nice paper led by @jenniaburt on how GPs think about deprescribing antihypertensives https://t.co/m65zII7gFe
RT @RichardJMcManus: Includes nice paper led by @jenniaburt on how GPs think about deprescribing antihypertensives https://t.co/m65zII7gFe
RT @RichardJMcManus: Includes nice paper led by @jenniaburt on how GPs think about deprescribing antihypertensives https://t.co/m65zII7gFe…
Includes nice paper led by @jenniaburt on how GPs think about deprescribing antihypertensives https://t.co/m65zII7gFe
RT @BiddyBike: I thought this was interesting - mindlines on how GPs approach deprescribing. No wonder it can't be done in 10 mins for an e…
(British Journal of General Practice) Conocimiento tácito de los médicos de cabecera sobre la deprescripción de antihipertensivos en pacientes mayores con multimorbilidad https://t.co/KhuBM2ihBO
I thought this was interesting - mindlines on how GPs approach deprescribing. No wonder it can't be done in 10 mins for an elderly patient on 10+ medicines. #pharmacists #deprescibing #SMR https://t.co/ztHJycagX5 https://t.co/KDbSM5yIAO
RT @K_Kuberska: Our paper is finally out 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity: a…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
RT @K_Kuberska: Our paper is finally out 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity: a…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
@johngabbay
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
great paper .@RichardJMcManus .@jenniaburt
Our paper is finally out 🎉🎉🎉 "GPs’ #mindlines on #deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice" https://t.co/MAk5Mk4EQQ #polypharmacy 💊💊💊 #Hypertension https://t.co/FF8wYkP52r
RT @BJGPjournal: 'Mindlines' – tacit, internalised guidelines developed over time – are critical for deprescribing, particularly in regards…
RT @EDeprescribeN: Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or advers…
Interviews GPs found they are confident in decisions to deprescribe when prompted by a trigger, such as a fall or adverse drug event, but less confident to attempt deprescribing in response to generalised concerns about polypharmacy. https://t.co/G9bWU51DC
Mindlinesに関するリサーチが久しぶりにでましたね。日本の家庭医にとっても大きなテーマだと思っています👉 GPs’ mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice https://t.co/jp5SXAgs5v
RT @BJGPjournal: 'Mindlines' – tacit, internalised guidelines developed over time – are critical for deprescribing, particularly in regards…
Super excited about this paper!
'Mindlines' – tacit, internalised guidelines developed over time – are critical for deprescribing, particularly in regards to antihypertensives in older patients. Read the new research by @jenniaburt @K_Kuberska and colleagues @PCU_Cambridge https://t.co
Qualitative interview study of 15 GPs found GPs are confident in deprescribing antihypertensives after a trigger, but less confident in response to generalised concerns about #polypharmacy #bjgp https://t.co/8o4Di8U4OC